MedPath

Use of Narrative Voice and Introduction Content to Improve Interactive Voice Response Surveys in Bangladesh and Uganda

Not Applicable
Completed
Conditions
Surveys and Questionnaires
Noncommunicable Diseases
Interventions
Other: Motivational Introduction
Other: Male Voice
Other: Female Voice
Other: Informational Introduction
Registration Number
NCT03772431
Lead Sponsor
Johns Hopkins Bloomberg School of Public Health
Brief Summary

This study evaluates the effect of two different narrative voices (one male and one female) and two different introductions (one with informational content and the other with additional motivational content) on interactive voice response (IVR) survey cooperation, response, refusal, and contact rates, as compared to a control group (male, informational), in Bangladesh and Uganda.

Detailed Description

Using random digit dialing (RDD) sampling techniques, participants were randomized to one of four arms: 1) male narrator and informational survey introduction, 2) male narrator and motivational survey introduction, 3) female narrator and informational survey introduction, and 4) female narrator and motivational survey introduction,male motivational, female informational, female motivational) which were then followed by a noncommunicable disease risk factor survey. This mobile phone survey was sent as an interactive voice response (IVR). In IVR surveys, participants use their touch tone key pad to answer pre-recorded questions. (i.e. If you are male, press 1; if you are female, press 2). This study was conducted in both Bangladesh and Uganda.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5580
Inclusion Criteria
  • Access to a mobile phone
  • Greater or equal to 18 years of age
  • In Bangladesh, conversant in either English or Bangla language. In Uganda, conversant in either Luo, Luganda, Runyakitara or English languages.
Exclusion Criteria
  • Less than 18 years of age

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Female InformationalInformational IntroductionFemale voice, informational introduction
Male MotivationalMotivational IntroductionMale voice, motivational introduction
Male InformationalMale VoiceMale voice, informational introduction
Male InformationalInformational IntroductionMale voice, informational introduction
Male MotivationalMale VoiceMale voice, motivational introduction
Female MotivationalMotivational IntroductionFemale voice, motivational introduction
Female InformationalFemale VoiceFemale voice, informational introduction
Female MotivationalFemale VoiceFemale voice, motivational introduction
Primary Outcome Measures
NameTimeMethod
Response Rate #4Through study completion, an average of one month

As defined by American Association for Public Opinion Research, response rate is defined as (I+P)/(I+P+R+eU) where I is complete interviews, P is partial interviews, R is refusals and breakoffs, and eU is the estimated eligible proportion of unknowns.

Cooperation rate #1Through study completion, an average of one month

As defined by American Association for Public Opinion Research, cooperation rate is defined as I/(I+P+R) where I is complete interviews, P is partial interviews, and R is refusals and breakoffs

Secondary Outcome Measures
NameTimeMethod
Refusal Rate #2Through study completion, an average of one month

As defined by American Association for Public Opinion Research, refusal rate is defined as (R)/(I+P+R+eU) where R is refusals and breakoffs, I is complete interviews, P is partial interviews, and eU is the estimated eligible proportion of unknowns

Contact Rate #2Through study completion, an average of one month

As defined by American Association for Public Opinion Research, contact rate is defined as (I+P+R)/(I+P+R+eU) where I is complete interviews, P is partial interviews, R is refusals and breakoffs, and eU is the estimated eligible proportion of unknowns

Trial Locations

Locations (2)

Makerere University School of Public Health

πŸ‡ΊπŸ‡¬

Kampala, Uganda

Institute of Epidemiology Disease Control and Research

πŸ‡§πŸ‡©

Dhaka, Bangladesh

Β© Copyright 2025. All Rights Reserved by MedPath